Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women
Top Cited Papers
Open Access
- 8 October 2002
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 106 (15), 1930-1937
- https://doi.org/10.1161/01.cir.0000033222.75187.b9
Abstract
Background— Nuclear magnetic resonance (NMR) offers an alternative, spectroscopic means of quantifying LDL and of measuring LDL particle size. Methods and Results— We conducted a prospective nested case-control study among healthy middle-aged women to assess LDL particle size (NMR) and concentration (NMR) as risk factors for future myocardial infarction, stroke, or death of coronary heart disease. Median baseline levels of LDL particle concentration (NMR) were higher (1597 vs 1404 nmol/L; P = 0.0001) and LDL particle size (NMR) was lower (21.5 vs 21.8 nm; P =0.046) among women who subsequently had cardiovascular events (n=130) than among those who did not (n= 130). Of these 2 factors, LDL particle concentration (NMR) was the stronger predictor (relative risk for the highest compared with the lowest quartile=4.17, 95% CI 1.96–8.87). This compared with a relative risk of 3.11 (95% CI 1.55–6.26) for the ratio of total cholesterol to HDL cholesterol and a relative risk of 5.91 (95% CI 2.65–13.15) for C-reactive protein. The areas under the receiver operating characteristic curves for LDL particle concentration (NMR), total cholesterol to HDL cholesterol ratio, and C-reactive protein were 0.64, 0.64, and 0.66, respectively. LDL particle concentration (NMR) correlated with several traditionally assessed lipid and nonlipid risk factors, and thus adjustment for these tended to attenuate the magnitude of association between LDL particle concentration (NMR) and risk. Conclusions— In this cohort, LDL particle concentration measured by NMR spectroscopy was a predictor of future cardiovascular risk. However, the magnitude of predictive value of LDL particle concentration (NMR) was not substantively different from that of the total cholesterol to HDL cholesterol ratio and was less than that of C-reactive protein.This publication has 11 references indexed in Scilit:
- Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I) trialThe American Journal of Cardiology, 2002
- Low-Density Lipoprotein Size, Pravastatin Treatment, and Coronary EventsJAMA, 2001
- Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemiaThe American Journal of Cardiology, 2001
- Low density lipoprotein particle size and risk of early-onset myocardial infarction in women.American Journal of Epidemiology, 2001
- Oral 17β-estradiol and medroxyprogesterone acetate therapy in postmenopausal women increases HDL particle sizeAtherosclerosis, 2001
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenThe New England Journal of Medicine, 2000
- The total apolipoprotein B/LDL-cholesterol ratio does not predict LDL particle sizeClinica Chimica Acta; International Journal of Clinical Chemistry, 1995
- Apolipoproteins and ischaemic heart disease: implications for screeningThe Lancet, 1994
- Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100Atherosclerosis, 1993
- A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial InfarctionThe New England Journal of Medicine, 1991